Search - tctmd.com

Displaying 1 - 20 of 31

Sort: Relevancy | Date

Presentation TCT 2023

Animal Studies of Cardiovascular Devices: The New CDRH Animal Study Guidance Document

Presenter: Natalie Miller

October 23, 2023

Presentation TCT 2023

Biocompatibility Assessment of Cardiovascular Devices: Just-in-Time Testing

Presenter: Girish Kumar

October 23, 2023

Presentation TCT 2022

CDT: New Devices, Drugs, and Duration?

Presenter: Andrew Sharp

September 19, 2022

Presentation TCT 2022

Novel Devices to Treat Hypertension: What Else Should We Expect in the Near Future?

Presenter: Felix Mahfoud

September 17, 2022

Presentation TCT 2019

What Are the Essential Differences Between Renal Denervation Devices and Procedures, and Do They Matter?

Presenter: Philipp Lurz

September 28, 2019

Presentation TCT 2019

Lesion Preparation/Modification Devices

Presenter: Robert Pyo

September 25, 2019

Presentation TCT 2018

Case #2: Multiple Long-term TAVI Failures: A Unique Case Treated With Three Different Devices

Presenter: Joshua P. Loh, João A Silveira, Andres Jr N Baysa, Alexandre Schaan Quadros

September 23, 2018

Presentation TCT 2018

Case #1: Percutaneous Closure of Anything With Something - The Off-Label Use of Devices. Mitral Leak, Post-MI VSD, Ascending Aorta Pseudoaneurysm, LV Pseudoaneurysm

Presenter: Joshua P. Loh, João A Silveira, Andres Jr N Baysa, Alexandre Schaan Quadros

September 23, 2018

Presentation TCT 2018

Neurology-Cardiology Partnership

Presenter: Robert J. Sommer, Christian Spies, Suzanne J. Baron, Reda Ibrahim, Carey D. Kimmelstiel, Srihari S. Naidu, Zoltan G. Turi, Dominik M. Wiktor

September 22, 2018

Presentation TCT 2018

Implantable Devices for Pulmonary Hypertension

Presenter: Ori Ben-Yehuda, Jay S. Giri, William T. Abraham

September 22, 2018

Presentation TCT 2018

Early Feasibility Studies for Device Evaluation

Presenter: Spencer B. King III, Bram D. Zuckerman, Andrew Farb

September 21, 2018

Presentation TCT 2018

Pre-Clinical and Clinical Trial Design and Endpoints for Device Approval

Presenter: Spencer B. King III, Bram D. Zuckerman, Chris Mullin, Roseann M White

September 21, 2018

Presentation TCT 2018

Practice Guideline Requirement for New Technology

Presenter: Spencer B. King III, Bram D. Zuckerman, Alice K. Jacobs

September 21, 2018

Presentation TCT 2018

CMS Requirement for Reimbursement for Innovation

Presenter: Spencer B. King III, Bram D. Zuckerman, Lori M Ashby

September 21, 2018

Presentation TCT 2018

Regulatory Requirement for Marketing Approval including the Parallel Review, NEST, and Beyond

Presenter: Spencer B. King III, Bram D. Zuckerman

September 21, 2018

Presentation TCT 2018

ISCTR Mission and Statement of Meeting Purpose

Presenter: Nabil Dib

September 21, 2018

Presentation TCT 2017

Putting the Evidence Together: Updating Guidelines, Patient Selection, and Insurance Coverage II - Cardiology Perspective

Presenter: Robert J. Sommer, David L. Tirschwell, John D. Carroll

November 01, 2017

Presentation TCT 2017

TAVR: Current Devices and Indications

Presenter: Debabrata Mukherjee, E. Murat Tuzcu, Vinod H. Thourani

November 01, 2017

Presentation TCT 2017

Flash Debate: Based on Clinical Studies, Embolic Protection Devices Should Infrequently Be Used During TAVR

Presenter: Gilles Dreyfus, Sanjay Kaul, Duane S. Pinto

November 01, 2017

Presentation TCT 2017

FDA Perspectives: Devices to Control Hypertension - Patient Populations, Endpoints and Other Considerations

Presenter: Hiren Mistry, Michael A. Weber

October 31, 2017

Advertisement

Animal Studies of Cardiovascular Devices: The New CDRH Animal Study Guidance Document

Biocompatibility Assessment of Cardiovascular Devices: Just-in-Time Testing

CDT: New Devices, Drugs, and Duration?

Novel Devices to Treat Hypertension: What Else Should We Expect in the Near Future?

What Are the Essential Differences Between Renal Denervation Devices and Procedures, and Do They Matter?

Lesion Preparation/Modification Devices

Case #2: Multiple Long-term TAVI Failures: A Unique Case Treated With Three Different Devices

Case #1: Percutaneous Closure of Anything With Something - The Off-Label Use of Devices. Mitral Leak, Post-MI VSD, Ascending Aorta Pseudoaneurysm, LV Pseudoaneurysm

Neurology-Cardiology Partnership

Implantable Devices for Pulmonary Hypertension

Early Feasibility Studies for Device Evaluation

Pre-Clinical and Clinical Trial Design and Endpoints for Device Approval

Practice Guideline Requirement for New Technology

CMS Requirement for Reimbursement for Innovation

Regulatory Requirement for Marketing Approval including the Parallel Review, NEST, and Beyond

ISCTR Mission and Statement of Meeting Purpose

Putting the Evidence Together: Updating Guidelines, Patient Selection, and Insurance Coverage II - Cardiology Perspective

TAVR: Current Devices and Indications

Flash Debate: Based on Clinical Studies, Embolic Protection Devices Should Infrequently Be Used During TAVR

FDA Perspectives: Devices to Control Hypertension - Patient Populations, Endpoints and Other Considerations

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content